Roc vs. Sux - The CURASMUR Trial

February 18, 2020 • 00:19:11
Roc vs. Sux - The CURASMUR Trial
Critical Care Perspectives in Emergency Medicine
Roc vs. Sux - The CURASMUR Trial

Feb 18 2020 | 00:19:11

/

Show Notes

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

September 19, 2017 • 00:32:38
Episode Cover

ED Mechanical Ventilation Pearls

In this podcast we discuss the pearls and perils of ED mechanical ventilation.  What are the numbers you NEED to know! We also discuss...

Listen

Episode 0

July 28, 2023 • 00:26:16
Episode Cover

Should We Transfuse Platelets Prior to CVC Placement?

Central venous catheter (CVC) placement is common in critically ill patients for a variety of indications.  Thrombocytopenia is also quite common in critically ill...

Listen

Episode

July 27, 2024 • 00:20:23
Episode Cover

What Oxygenation Strategy Should We Use for COVID-19 Patients?

Patients with COVID-19 can require supplemental oxygen for acute hypoxemic respiratory failure.  While international guidelines recommend a target SpO2 between 90-96%, a safe oxygenation...

Listen